Y300-0669 Screening compound: 1-acetyl-N-[4-(4-methylpiperazin-1-yl)phenyl]-2,3-dihydro-1H-indole-5-sulfonamide

Y300-0669 Screening compound: 1-acetyl-N-[4-(4-methylpiperazin-1-yl)phenyl]-2,3-dihydro-1H-indole-5-sulfonamide
Y300-0669 Screening compound: 1-acetyl-N-[4-(4-methylpiperazin-1-yl)phenyl]-2,3-dihydro-1H-indole-5-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y300-0669
1-acetyl-N-[4-(4-methylpiperazin-1-yl)phenyl]-2,3-dihydro-1H-indole-5-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y300-0669

Molecular Formula

C21H26N4O3S (C21 H26 N4 O3 S)

Compound Name

1-acetyl-N-[4-(4-methylpiperazin-1-yl)phenyl]-2,3-dihydro-1H-indole-5-sulfonamide

IUPAC name

1-acetyl-N-[4-(4-methylpiperazin-1-yl)phenyl]-23-dihydro-1H-indole-5-sulfonamide

SMILES

CC(N(CC1)c(cc2)c1cc2S(Nc(cc1)ccc1N1CCN(C)CC1)(=O)=O)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

414.53

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.018

Distribution Coefficient, logD

1.450

Water Solubility, LogSw

-2.96

Polar Surface Area

64.235

Acid Dissociation Constant (pKa)

9.50

Base Dissociation Constant (pKb)

7.83

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

38.10

Y300-0669 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • Receptor's ligands

References: we are preparing a list of scientific research reports with Y300-0669 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y300-0669?
Check Price and Availability of Y300-0669, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y300-0669 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y300-0669
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y300-0669
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y300-0669 available by request